Skip to content
MedCompare

Enzalutamide

Also known as Xtandi (us), Enzalutide (india)

Cancer & Oncology
Save $4,314/mo
24× cheaper

Enzalutamide is used to treat certain types of prostate cancer. Enzalutamide is in a class of medications called androgen receptor inhibitors.

United States
$4,503
per month
India
$189
per month
You save
$4,314
96% cheaper in India
255.7K US scripts/yr$1.1B potential annual savings$1.2B US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC21H16F4N4O2S

SMILES: CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C

Compare the price
US price$4,503per month
India price$189per month
You save$4,31496% less

Based on 30 units per month. US $150.09 vs India $6.30 per unit.

Total over 1 periodSave $4,314$4,503 → $189
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$25,883
Estimated travel cost
− $2,300
Net savings after travel
$23,583

Even after travel, you could come out ahead by about $23,583.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Enzalutamide is filled about 255.7K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$1.2B
If sourced from India
$48.3M
Potential annual savings
$1.1B
−96%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.